Xponance’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8M | Buy |
899,601
+44,732
| +5% | +$1.08M | 0.18% | 88 |
|
|
2025
Q1 | $21.7M | Buy |
854,869
+3,621
| +0.4% | +$91.8K | 0.21% | 81 |
|
|
2024
Q4 | $22.6M | Buy |
851,248
+34,344
| +4% | +$911K | 0.21% | 69 |
|
|
2024
Q3 | $23.6M | Sell |
816,904
-71,728
| -8% | -$2.08M | 0.23% | 70 |
|
|
2024
Q2 | $24.9M | Sell |
888,632
-50,202
| -5% | -$1.4M | 0.25% | 56 |
|
|
2024
Q1 | $26.1M | Buy |
938,834
+47,810
| +5% | +$1.33M | 0.27% | 60 |
|
|
2023
Q4 | $25.7M | Buy |
891,024
+91,843
| +11% | +$2.64M | 0.31% | 53 |
|
|
2023
Q3 | $26.5M | Buy |
799,181
+61,069
| +8% | +$2.03M | 0.36% | 41 |
|
|
2023
Q2 | $27.1M | Buy |
738,112
+335
| +0% | +$12.3K | 0.36% | 40 |
|
|
2023
Q1 | $30.1M | Buy |
737,777
+37,525
| +5% | +$1.53M | 0.44% | 35 |
|
|
2022
Q4 | $35.9M | Buy |
700,252
+102,024
| +17% | +$5.23M | 0.58% | 27 |
|
|
2022
Q3 | $26.2M | Buy |
598,228
+81,844
| +16% | +$3.58M | 0.5% | 28 |
|
|
2022
Q2 | $27.1M | Sell |
516,384
-11,845
| -2% | -$621K | 0.54% | 28 |
|
|
2022
Q1 | $27.3M | Buy |
528,229
+7,091
| +1% | +$367K | 0.45% | 33 |
|
|
2021
Q4 | $30.8M | Buy |
521,138
+105,259
| +25% | +$6.22M | 0.48% | 33 |
|
|
2021
Q3 | $17.9M | Sell |
415,879
-27,461
| -6% | -$1.18M | 0.34% | 56 |
|
|
2021
Q2 | $17.4M | Sell |
443,340
-42,975
| -9% | -$1.68M | 0.32% | 62 |
|
|
2021
Q1 | $17.6M | Buy |
486,315
+996
| +0.2% | +$36.1K | 0.37% | 50 |
|
|
2020
Q4 | $17.9M | Sell |
485,319
-20,194
| -4% | -$743K | 0.39% | 47 |
|
|
2020
Q3 | $17.6M | Sell |
505,513
-58,255
| -10% | -$2.03M | 0.43% | 44 |
|
|
2020
Q2 | $17.5M | Buy |
+563,768
| New | +$17.5M | 0.45% | 43 |
|